TROP2 and its Impact on Glycolysis in Cancer: A Comprehensive Review

Summary: The article 'Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment' explores the metabolic networks in tumors driven by mutant KRAS, focusing on tissue specificities and the role of the microenvironment. The authors, Samuel A. Kerk, Thales Papagiannakopoulos, Yatrik M. Shah, and Costas A. Lyssiotis, investigate how mutant KRAS affects metabolic pathways in different tissues and how the tumor microenvironment influences these networks.

Famous articles concerning TROP2:

1. 'TROP2 expression in cancer: A potential therapeutic target' by Trerotola et al. (2013)
2. 'TROP2: A promising therapeutic target in squamous cell carcinoma of the head and neck' by Zhang et al. (2019)
3. 'TROP2 as a novel prognostic marker in squamous cell carcinoma of the oral cavity' by Liu et al. (2018)

Molecular pathways involving TROP2:

1. The Wnt/β-catenin signaling pathway
2. The PI3K/Akt signaling pathway
3. The MAPK/ERK signaling pathway
4. The EGFR signaling pathway
5. The Notch signaling pathway

Effect of TROP2 on glycolysis: There is limited research on the direct influence of TROP2 on glycolysis. However, some studies suggest that TROP2 may indirectly affect glycolysis through its involvement in the PI3K/Akt and MAPK/ERK signaling pathways, which play a role in regulating glucose metabolism.

Promising molecular mechanisms linking TROP2 and glycolysis:

1. The activation of the PI3K/Akt signaling pathway by TROP2 can enhance glucose uptake and promote glycolysis.
2. TROP2 may interact with EGFR and activate downstream signaling pathways, such as the MAPK/ERK pathway, which can influence glycolysis.
3. TROP2-mediated activation of the Wnt/β-catenin signaling pathway may indirectly regulate glycolysis through its impact on glucose metabolism-related genes.

Please note that the information provided is based on general knowledge and may not encompass all existing articles or the latest research developments on TROP2 and its molecular pathways.